TABLE 2.
Patient | Age, y | Procedure | Reason for exclusion | Baseline Cr | Postoperative peak Cr<72 h |
---|---|---|---|---|---|
1 | 50 | LV mass excision | No comparable procedure | 1.5 | 1.4 |
2 | 62 | CABG × 4 | Preoperative ECMO and AKI requiring CVVHD | — | — |
3 | 49 | CABG × 2 | Preoperative ESRD | — | — |
4 | 86 | CABG × 3 | No match available | 1.3 | 2.3 |
5 | 54 | OHT | Tacrolimus toxicity | 1.5 | 3.4 |
6 | 77 | Robotic tricuspid valve repair | No match available | 1.3 | 1.5 |
7 | 51 | AVR | No match available | 1.3 | 1.3 |
8 | 77 | CABG × 4 | Reoperation excluded (index CABG was included) | 1.4 | 1.6 |
9 | 76 | CABG × 3 | Preoperative ESRD | — | — |
10 | 64 | CABG × 3 | No match available | 1.1 | 1.0 |
11 | 78 | CABG × 3 and LV thrombectomy | VF arrest on transfer from OR to ICU | 1.6 | 1.4 |
12 | 56 | CABG × 3 | Preoperative ESRD | — | — |
Serum creatinine in milligrams/deciliter. Cr, Creatinine; LV, left ventricle; CABG, coronary artery bypass grafting; ECMO, extracorporeal membrane oxygenation; AKI, acute kidney injury; CVVHD, continuous venovenous hemodialysis; ESRD, end-stage renal disease on dialysis; OHT, orthotopic heart transplantation; AVR, aortic valve replacement; VF, ventricular fibrillation; OR, operating room; ICU, intensive care unit.